Media Summary: Adrian Isaacs, PhD is Professor of Neurodegenerative Filmed at our inaugural Mind Matters Science Symposium, Prof. Dennis Selkoe (HMS) takes us through his research which ... UC San Diego Dermatology Grand Rounds lecture: “Derrmatomyositis:

New Disease Mechanisms And Therapeutic - Detailed Analysis & Overview

Adrian Isaacs, PhD is Professor of Neurodegenerative Filmed at our inaugural Mind Matters Science Symposium, Prof. Dennis Selkoe (HMS) takes us through his research which ... UC San Diego Dermatology Grand Rounds lecture: “Derrmatomyositis: The macula is responsible for high-acuity vision and is disproportionately affected by degenerative retinal Welcome to Episode 157 of the DoctorPodcasts Show! In this episode, host Dr. Robert Cykiert interviews board-certified ... Most central nervous system drugs target individual proteins to block

Jair C. Soares, M.D., Ph.D. the Executive Director, UTHealth, Harris County Psychiatric Center talks about Bipolar disorder: brain ... In this video, we present "Applied Pathophysiology and Pharmacology: Understanding Recent discoveries show that some neurodegenerative disorders occur because of abnormalities in the processing of RNA in the ... The annual Astute Clinician Lecture was established in 1998 through a gift from the late Dr. Robert W. Miller and his wife, Haruko. In this episode, host Brandon Li speaks with Cuong Do, CEO of BioVie, to explore the intersection of inflammation and ... Andrés F. Muro, ICGEB, Mouse Molecular Genetics, Group Leader Trieste - ITALY speaks on "Crigler-Najjar Syndrome type I_ ...

Photo Gallery

New Disease Mechanisms and Therapeutic Approaches for C9orf72 ALS/FTD
MMSS Keynote: Molecular Mechanisms ​ and Therapeutic Targets ​ in Alzheimer's Disease​
Victoria Werth, MD   Derrmatomyositis New insights into disease mechanisms and therapeutic approache
Building a Human Macula on a Chip Platform to Study Disease Mechanisms and Test New Therapies
LUMVOA: New Breakthrough FDA-Approved Biologic Drug Treatment for Thyroid Eye Disease (TED)
Assembly Modulation: A New Drug Discovery Strategy for CNS Diseases
Bipolar disorder: brain mechanisms of disease progression and new therapeutic interventions
Applied Pathophysiology and Pharmacology: Understanding Disease Mechanisms (3 Minutes)
Shuying Sun: RNA Dysregulation in Neurodegenerative Disorders – From Mechanisms to New Therapies
Taking Cues from Single Patients to Discover Genes, Mechanisms, and Therapeutic Approaches
One Mechanism, Three Conditions: A New Direction in Neurological Treatment
Chapter 5 - Mechanisms of Disease
View Detailed Profile
New Disease Mechanisms and Therapeutic Approaches for C9orf72 ALS/FTD

New Disease Mechanisms and Therapeutic Approaches for C9orf72 ALS/FTD

Adrian Isaacs, PhD is Professor of Neurodegenerative

MMSS Keynote: Molecular Mechanisms ​ and Therapeutic Targets ​ in Alzheimer's Disease​

MMSS Keynote: Molecular Mechanisms ​ and Therapeutic Targets ​ in Alzheimer's Disease​

Filmed at our inaugural Mind Matters Science Symposium, Prof. Dennis Selkoe (HMS) takes us through his research which ...

Victoria Werth, MD   Derrmatomyositis New insights into disease mechanisms and therapeutic approache

Victoria Werth, MD Derrmatomyositis New insights into disease mechanisms and therapeutic approache

UC San Diego Dermatology Grand Rounds lecture: “Derrmatomyositis:

Building a Human Macula on a Chip Platform to Study Disease Mechanisms and Test New Therapies

Building a Human Macula on a Chip Platform to Study Disease Mechanisms and Test New Therapies

The macula is responsible for high-acuity vision and is disproportionately affected by degenerative retinal

LUMVOA: New Breakthrough FDA-Approved Biologic Drug Treatment for Thyroid Eye Disease (TED)

LUMVOA: New Breakthrough FDA-Approved Biologic Drug Treatment for Thyroid Eye Disease (TED)

Welcome to Episode 157 of the DoctorPodcasts Show! In this episode, host Dr. Robert Cykiert interviews board-certified ...

Assembly Modulation: A New Drug Discovery Strategy for CNS Diseases

Assembly Modulation: A New Drug Discovery Strategy for CNS Diseases

Most central nervous system drugs target individual proteins to block

Bipolar disorder: brain mechanisms of disease progression and new therapeutic interventions

Bipolar disorder: brain mechanisms of disease progression and new therapeutic interventions

Jair C. Soares, M.D., Ph.D. the Executive Director, UTHealth, Harris County Psychiatric Center talks about Bipolar disorder: brain ...

Applied Pathophysiology and Pharmacology: Understanding Disease Mechanisms (3 Minutes)

Applied Pathophysiology and Pharmacology: Understanding Disease Mechanisms (3 Minutes)

In this video, we present "Applied Pathophysiology and Pharmacology: Understanding

Shuying Sun: RNA Dysregulation in Neurodegenerative Disorders – From Mechanisms to New Therapies

Shuying Sun: RNA Dysregulation in Neurodegenerative Disorders – From Mechanisms to New Therapies

Recent discoveries show that some neurodegenerative disorders occur because of abnormalities in the processing of RNA in the ...

Taking Cues from Single Patients to Discover Genes, Mechanisms, and Therapeutic Approaches

Taking Cues from Single Patients to Discover Genes, Mechanisms, and Therapeutic Approaches

The annual Astute Clinician Lecture was established in 1998 through a gift from the late Dr. Robert W. Miller and his wife, Haruko.

One Mechanism, Three Conditions: A New Direction in Neurological Treatment

One Mechanism, Three Conditions: A New Direction in Neurological Treatment

In this episode, host Brandon Li speaks with Cuong Do, CEO of BioVie, to explore the intersection of inflammation and ...

Chapter 5 - Mechanisms of Disease

Chapter 5 - Mechanisms of Disease

The Human Body in Health &

A. Muro - C.-Najjar S. type I_ new insights into disease mechanisms and therapy using Ugt1 KO mice

A. Muro - C.-Najjar S. type I_ new insights into disease mechanisms and therapy using Ugt1 KO mice

Andrés F. Muro, ICGEB, Mouse Molecular Genetics, Group Leader Trieste - ITALY speaks on "Crigler-Najjar Syndrome type I_ ...